Navigation Links
CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA
Date:10/4/2011

MENLO PARK, Calif., Oct. 4, 2011 /PRNewswire/ -- CV Ingenuity, a privately-held medical device company, today announced the close of a $16 million Series B round of financing led by New Enterprise Associates (NEA), a leading global venture capital firm. Existing investors BioStar Ventures, Synergy Ventures and Western Technology also participated in the round. CV Ingenuity (CVI), which is focused on the development of a drug-eluting balloon platform technology that aims to treat peripheral artery disease while also working to prevent restenosis, will use this latest round of funding to accelerate product development and expand the leadership team.  

"I am extremely pleased with the significant financial commitment that NEA and our existing investors have made to CVI in this funding round," said CEO Duke Rohlen. "Their financial support is further validation of our technology, our leadership team and our strategy to develop a drug eluting balloon technology to treat patients suffering from peripheral artery disease. We are thrilled to partner with these blue-chip investors as we accelerate into clinical development."

The afflicted patient population that CVI's technology will treat is substantial. It is estimated that PAD currently affects between eight and 12 million adults-and is the leading cause of amputation in patients over 50. Hospitalization costs of PAD alone are estimated to exceed $21 billion annually.

"CVI is addressing an important and overlooked disease within a market that has an estimated $1 billion potential," said NEA General Partner Ryan Drant. "They have developed an extremely sound technology platform and have a tremendously talented and resourceful team that is now in a position to expand and rapidly develop this promising device." Mr. Drant and Justin Klein, a principal with NEA, will join the CVI Board of Directors.

About CV Ingenuity

CV Ingenuity is a Palo Alto, CA based medical device compa
'/>"/>

SOURCE CV Ingenuity
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA
2. Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA
3. Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research
4. Medical Alarm Concepts Announces Beta Testing of Next Generation MediPendantâ„¢ Medical Alarm Technology!
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
6. Varian Medical Systems Announces New Management Positions
7. The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Pharmaceutical Product Development, Inc. in Connection With Sale of the Company to The Carlyle Group and Hellman & Friedman
8. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
9. Concord Medical Services Announces Share Repurchase Program
10. Sysmex Announces Newest Version of Clinical Laboratory Management Software
11. Atrium Announces the Publication of the COBEST Trial by the Journal of Vascular Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Research and ... the "Future Horizons and Growth Strategies in ... and Country Forecasts" report to their offering. ... the European Blood Banking Market 2015 is a ... current suppliers and potential market entrants identify and ...
(Date:7/1/2015)... July 1, 2015  Celsion Corporation (NASDAQ: CLSN ... Michael H. Tardugno , Chairman, President and CEO, ... Healthcare Conference on Wednesday, July 8, 2015, at 4:15 ... Parker Meridien Hotel located at 119 W. 56th Street, ... A copy of the presentation will be available ...
(Date:7/1/2015)... (Continental) announced it is expanding its Baltimore -based clinical studies network and ... for unique patient populations.  Photo - ... ... ... "Continental hosts clinical studies for physicians ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
(Date:7/1/2015)... GEORGIA (PRWEB) , ... July 01, 2015 , ... ... Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance ... grant to develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... which DNA is wound, histones, remain constant in the brain, never changing after development ... have discovered that histones are steadily replaced in brain cells throughout life – a ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative leaders in pharmacy ... pharmacy operations, announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. ... at the Venetian Las Vegas, Nevada. During this event, SuiteRx will be ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC ... plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which ... U.S. Spirulina* production base, began in May 2014. After commissioning, commercial production is ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... Set for March 6th - 8th, the 2016 meeting will be held at the ... fundamentals of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... , , LOS ANGELES, Sept. ... manufacturer of BPA-free baby bottles that provide a safe alternative ... currently banned in Canada, Minnesota, Connecticut and under scrutiny in ... Assembly members to support the Toxics-Free Babies and Toddlers ...
... of voting Iowans believe the government should be given additional ... them sick, according to a new poll commissioned by The ... Opinion Strategies. Support for stronger food protections is ... The statewide survey of 511 registered voters, conducted between August ...
... MOUNT LAUREL, N.J., Sept. 2 MedQuist Inc. (Nasdaq: ... a five-year $25 million revolving credit facility. The credit ... an option whereby the Company may increase its maximum credit ... The credit facility is a working capital facility that ...
... , , MONTREAL, ... in R&D, in partnership with industry leading manufacturers (Sirona, ... Systems today announced the launch of ProDrive products nationwide ... Dental Canada. Canada,s largest dental products reseller, Patterson has ...
... , , WASHINGTON, Sept. 2 ... to President Obama inviting him to address a Joint Session of Congress on Wednesday, ... text of the letter to the President: , , September ... , Washington, D.C. 20500 , , Dear Mr. President: , ...
... Md., Sept. 2 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... services in the People,s Republic of China, today,announced its participation in ... Healthcare Corporate Day, to be held September 11, 2009, ... institutional investors, throughout the day., ...
Cached Medicine News:Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 2Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 3Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 4Health News:Pew poll: 9 in 10 Iowa voters support more government oversight of food 2Health News:MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend 2Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Chindex International Announces September Investor Conferences Participation 2
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Hook design lifts and separates tissue for efficient dissection. Cautery action facilitates immediate control of bleeders....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Medicine Products: